Bedeutender Fortschritt: Cetuximab in Der Erstlinientherapie Von Kopf-Hals-Tumoren
Info Onkologie
doi 10.1007/bf03362735
Full Text
Abstract
Available in
Date
March 1, 2010
Authors
Unknown
Publisher
Springer Science and Business Media LLC
doi 10.1007/bf03362735
Available in
March 1, 2010
Unknown
Springer Science and Business Media LLC